Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DOD Biotech PCLBKK:DOD-R -5.84%67 Shiller PE Ratio is 5.09 as of Sep. 05, 2026, which is 56% below its 10-year median of 11.47. GuruFocus rates BKK:DOD-R with a GF Score™ of 67/100 and a GF Value™ of ฿1.52. The stock has 6 warning signs investors should review. Among 1,129 Consumer Packaged Goods companies, DOD Biotech PCL ranks better than 85.39% on this metric.
As of today (2026-09-05), DOD Biotech PCL's current share price is ฿0.96667. DOD Biotech PCL's E10 for the quarter that ended in Jun. 2026 was ฿0.19. DOD Biotech PCL's Shiller PE Ratio for today is 5.09.
The historical rank and industry rank for DOD Biotech PCL's Shiller PE Ratio or its related term are showing as below:
BKK:DOD-R'
s Shiller PE Ratio Range Over the Past 10 Years
Min: 6.93 Med: 11.47 Max: 14.43
Current: 7.07
During the past years, DOD Biotech PCL's highest Shiller PE Ratio was 14.43. The lowest was 6.93. And the median was 11.47.
BKK:DOD-R's Shiller PE Ratio is ranked better than 85.39% of 1129
companies
in the Consumer Packaged Goods industry
Industry Median: 17.66
vs BKK:DOD-R: 7.07
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
DOD Biotech PCL's adjusted earnings per share data for the three months ended in Jun. 2026 was ฿0.002. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ฿0.19 for the trailing ten years ended in Jun. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
DOD Biotech PCL (BKK:DOD-R) Shiller PE Ratio Explanation
Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.
Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.
Be Aware
Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.
DOD Biotech PCL Shiller PE Ratio Related Terms
DOD Biotech PCL Shiller PE Ratio Historical Data
* Premium members only.
The historical data trend for DOD Biotech PCL's Shiller PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:DOD-R vs KHC, GIS: Shiller PE Ratio Comparison
For the Packaged Foods subindustry, DOD Biotech PCL's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DOD Biotech PCL Shiller PE Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, DOD Biotech PCL's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where DOD Biotech PCL's Shiller PE Ratio falls into.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
DOD Biotech PCL's Shiller PE Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DOD Biotech PCL's E10 for the quarter that ended in Jun. 2026 is calculated as:
For example, DOD Biotech PCL's adjusted earnings per share data for the three months ended in Jun. 2026 was:
Add all the adjusted EPS together and divide 10 will get our E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
DOD Biotech PCL (BKK:DOD-R) has a Shiller PE Ratio of 5.09 as of Sep. 05, 2026. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on DOD Biotech PCL and its competitors. This is 56% below median its historical median of 11.47. Over the past decade, DOD Biotech PCL's Shiller PE Ratio has ranged from 6.93 to 14.43. According to the industry distribution chart, DOD Biotech PCL ranks #165 out of 1129 companies in the Consumer Packaged Goods industry, placing it in the top 14.6%.
Is DOD Biotech PCL's Shiller PE Ratio too high?
DOD Biotech PCL's current Shiller PE Ratio of 5.09 is 56% below median its 10-year median of 11.47. Over the past 10 years, this metric has ranged from a low of 6.93 to a high of 14.43. The Consumer Packaged Goods industry median Shiller PE Ratio is 17.66. DOD Biotech PCL's value of 5.09 is 71.2% below this industry median. Based on the distribution chart, DOD Biotech PCL ranks #165 out of 1129 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, DOD Biotech PCL has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does DOD Biotech PCL's Shiller PE Ratio compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, DOD Biotech PCL ranks #165 out of 1129 companies for Shiller PE Ratio. This places DOD Biotech PCL in the top 15% of its industry — outperforming the majority of peers. The industry median Shiller PE Ratio is 17.66. DOD Biotech PCL's value of 5.09 is 71.2% below this benchmark. Historically, DOD Biotech PCL's own Shiller PE Ratio has ranged from 6.93 to 14.43 over the past decade. While the company's 10-year median is 11.47 vs. the industry median of 17.66, DOD Biotech PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shiller PE Ratio for a Consumer Packaged Goods company?
The median Shiller PE Ratio among Consumer Packaged Goods companies is 17.66, based on 1,129 companies in the industry. Companies in the top quartile (top 25%) have a Shiller PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Shiller PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DOD Biotech PCL's current Shiller PE Ratio of 5.09 is 71.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shiller PE Ratio mean?
A high Shiller PE Ratio can signal that a stock is expensive relative to its fundamentals. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on DOD Biotech PCL and its competitors. For the Consumer Packaged Goods industry, the median Shiller PE Ratio is 17.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DOD Biotech PCL's current Shiller PE Ratio is 5.09, which is 56% below median its own 10-year median of 11.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DOD Biotech PCL stock overvalued right now?
DOD Biotech PCL (BKK:DOD-R) has a current Shiller PE Ratio of 5.09. The stock's GF Value™ is ฿1.52, compared to a current price of ฿0.97 — trading 36.4% below its estimated fair value. The current Shiller PE Ratio is 5.09, which is 56% below median its 10-year median of 11.47 and 71.2% below the Consumer Packaged Goods industry median of 17.66. DOD Biotech PCL's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shiller PE Ratio calculated?
Shiller PE Ratio is calculated from a company's financial statements. For DOD Biotech PCL (BKK:DOD-R), the current Shiller PE Ratio is 5.09 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DOD Biotech PCL (BKK:DOD-R) Overvalued in 2026?
Based on GuruFocus' analysis, DOD Biotech PCL stock appears to be undervalued.
The current stock price of ฿0.97 is trading 36.4% below its estimated GF Value™ of ฿1.52.
Key valuation signals for BKK:DOD-R:
Shiller PE Ratio: 5.09 (56% below median its 10-year median of 11.47)
GF Value™: ฿1.52 vs. price of ฿0.97 (36.4% below fair value)
Industry Position: 71.2% below the Consumer Packaged Goods median (#165 of 1129)
No single metric tells the full story. See the BKK:DOD-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The group is principally engaged in the supplement business. Its operations are carried on only in Thailand. Its products include: Capsule; Gel; Jelly; Powder for making drinks; Concentrated water extract (Shot Drink); Softgel; Tablet; Probiotics; Gummies; and Direct-to-Mouth Packaging.
67GF Score
Get the complete analysis for BKK:DOD-R
Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:DOD-R has been successfully added to your 
